Suffer Heart Attack or Stroke While Taking Uloric® (febuxostat)?
Uloric®, A New Gout Medication Is Now Linked To Increased Risk of Death Due To Serious Cardiovascular Side Effects
Did you (or a loved one) take Uloric® (febuxostat) and experience any of the following?
- Heart Attack
AT A GLANCE: The FDA on February 21st, 2019 issued a "Black Box Warning" (the most severe warning the FDA can issue) for Uloric® (febuxostat) after a safety clinical trial showed an increased risk of death from heart attacks and strokes in patients taking Uloric® (febuxostat).
The FDA has advised the medical community that Uloric® (febuxostat) should no longer be prescribed to the general gout patient population, or to those patients at high risk for cardiovascular events.
COULD ULORIC® HAVE CAUSED YOUR SERIOUS EVENT?
If you think you may have been affected by this, you may be eligible for financial compensation for having not been warned of these risks.
Talk to one of our attorneys today. We are offering free legal consultations for a limited time. Click the button below to request a conversation with our legal team and discover the latest updates in this investigation...
It's totally free and without obligation.
We are investigating cases across all 50 states.
WATCH AS OUR LAW FIRM'S ASSOCIATE COUNSEL DESCRIBES THE LEGAL IMPACT OF THESE NEW FINDINGS
"As they [Takeda Pharmaceuticals] see adverse events, they have to report them to the FDA. As these adverse events started piling up, and piling up, and piling up, eventually the FDA said, 'We might have a problem here. We need to take a closer look'. When they [FDA] took that closer look, they found that Uloric® specifically had an increased risk of cardiovascular related death as compared to the generics."
-- WESLEY BOWDEN, ESQ. (Attorney & Associate Counsel)
Did Patients Really Need Uloric®? Or Was It Rushed To Market Simply For Profits?
Please watch the videowhich explains the current investigation into Uloric® -- and what the newly discovered health risks mean for patients and the medical community.
Uloric® (febuxostat) was brought to market by Takeda® Pharmaceuticals in 2009. It was marketed as an alternative to Zyloprim (allopurinol), a generic drug that has been on the market for many decades with a stellar reputation for being inexpensive, safe and effective in the treatment of gout.
If an inexpensive, safe and effective drug for gout already existed, then why did Takeda® Pharmaceuticals decide to introduce a MORE expensive, LESS proven drug that DOESN'T show any increased effectiveness over existing generics?
As is all too common with drug sales, the profits are made off the patents -- and drugs that are cheap have little margin for profit.
So drug companies create “new” drugs with modified properties that allow for a new patent. The patent then allows pharmaceuticals to charge MORE for their medication and protect against generics -- all while marketing it as the “latest and greatest” with little track record for safety.
Two Frightening Studies Prompts FDA To Act Quickly: Uloric® Linked To Death...
In 2017, the manufacturer of Uloric® (Takeda Pharmaceuticals) was mandated by the FDA to conduct a safety clinical trial for Uloric®. The findings of this safety trial were frightening -- the study showed an increased risk of heart-related deaths and deaths from all causes compared to the alternative gout medication, allopurinol.
Then, in March 2018, a safety study published in the New England Journal of Medicine showed that compared to the alternative generic gout medication allopurinol, the new Uloric® (febuxostat) was linked to a statistically significant increase in cardiovascular related deaths (due to heart attack and stroke).
These alarming results prompted the FDA to conduct a hearing on the safety of Uloric® (febuxostat).
Have you taken Uloric® (febuxostat)?
FDA Meeting About Uloric® In Jan 2019: Recommends Halting Uloric® Use In General Gout Population
In January, the FDA held a joint meeting between the Drug Safety & Risk Management Advisory Committee and the Arthritis Advisory Committee to discuss the safety of Uloric®.
Both panels agreed: Uloric® posed a significant enough risk to patients that updated prescribing information was needed for the medical community.
The FDA's updated prescribing mandate for Uloric® was the following:
And as if the FDA's prescribing update couldn't be any more telling of the dangers of Uloric®, the FDA chose to apply its most severe health warning to Uloric®...
FDA Issues Infamous "Black Box Warning": Uloric® Linked To Life Threatening Side Effects
On February 21, 2019, the FDA issued its strongest warning for Uloric®, the infamous "Black Box Warning"...
Further recommendations were made to physicians that Uloric® should not be used with patients who have a history of cardiovascular events or are at high risk for cardiovascular events, such as heart attack and stroke.
No longer is Uloric® to be prescribed to patients as a "first-line therapy" for gout arthritis, but only to those patients who cannot tolerate the safer alternative, allopurinol.
Were you prescribed Uloric® (febuxostat)?
What Every Uloric® User Should Know...
What To Do If You (Or A Loved One) Suffered A Heart Attack or Stroke While Taking Uloric®
The law protects patients from dangerous drugs that can cause serious harm...
If you (or a loved one) used Uloric® for gout arthritis or hyperuricemia related conditions and subsequently experienced a heart attack, stroke or even death, this may be the most important message you will ever read.
Here is why...
The out medication Uloric® (febuxostat) has been linked to the following complications...
- Heart attack
When Drug Manufacturers Fail To Properly Warn of Dangers, Innocent Patients Become Victims
As a result of the manufacturer of Uloric® failing to properly warn patients and doctors of these adverse cardiovascular risks, you or your loved one likely suffered serious physical and emotional stress, along with unintended financial burdens -- like doctor or hospital visits, time off work, necessary treatments and/or surgeries related to the cardiovascular event.
Why should you suffer and be responsible for the damage caused by a drug manufacturer's failure to properly warn of such risks?
As a victim of a drug that potentially FAILED to properly warn you of such cardiovascular risks with their medication, you may be entitled to what are called "money damages", which is just a legal term for money awarded from individual lawsuits, settlements and class action lawsuits.
All potential Uloric® lawsuits are currently being investigated on the grounds that Takeda Pharmaceuticals® (maker of Uloric®)...
- failed to properly warn patients and doctors of known cardiovascular event risks
How To Pursue Financial Compensation If You (Or A Loved One) Was Affected...
Our legal team has reviewed the available evidence and our experience tells us that we are in prime position to represent victims who have suffered health and financial consequences due to Uloric® use.
We are currently accepting cases nationally from all 50 states.
Get A Free Legal Consultation With Our Uloric® Lawyers Today
For a limited time, our Uloric® lawsuit lawyers are offering FREE legal consultations to those who may have suffered both physically and financially due to Uloric®.
This is your opportunity to have a conversation with an experienced attorney who can answer all your questions and help you determine if you are eligible to pursue financial compensation.
Act Now Because There Is A Limited Window of Time To Pursue A Legal Case
There is a very small window of time for victims to seek financial compensation after an injury -- it is called the "statute of limitations" and the time window for pursuing a case is different in each state.
So please do not wait to speak to an attorney because you do not want to miss your opportunity to pursue a Uloric® settlement or lawsuit.
Here is how to get started:
Fill out the free consultation form below and one of our attorneys will promptly call you to discuss your case.
This consultation is FREE. There is no-risk and no obligation. This is simply your opportunity to understand if you have a case and discover what your legal options are in terms of pursuing financial compensation.
HIGHEST RATINGS FOR ETHICAL STANDARDS AND LEGAL ABILITY
Greenberg & Bederman has achieved the highest possible rating for ethical standards and legal ability by Martindale-Hubbell® for 2019 (and previous years as well). They describe our perfect 5.0 rating as, "a significant rating accomplishment -- a testament to the fact that a lawyer’s peers rank him or her at the highest level of professional excellence and ethical standards."
Additionally, our attorneys have won numerous 2019 Super Lawyers™ Awards.
So fill out the form below, or call our legal team right now at 866-533-9120 to get your free legal consultation.
Get Your FREE Legal Consultation!
Simply fill out the form below and one of our lawyers will promptly call you for your free legal consultation!
Want to call us instead? Call our attorneys at 866-533-9120 right now!
AWARDED SUPER LAWYER™ STATUS IN 2019
The Law Office of Greenberg & Bederman has numerous attorneys that were awarded the prestigious Super Lawyers™ status. Super Lawyers™ is an independent, attorney ranking organization that awards attorneys each year based on many factors, including affinity with other lawyers.
Copyright © 2019 Greenberg & Bederman, LLC.
All Rights Reserved.
Greenberg & Bederman, LLC is associated with Levin Papantonio
Click to Scroll to Top of Page